U.S. Markets open in 9 hrs 23 mins

Hemispherx Biopharma, Inc. :HEB-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

CapitalCube
Capital Cube
Hemispherx Biopharma, Inc. :HEB-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017

Categories: Yahoo FinanceGet free summary analysis Hemispherx Biopharma, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Hemispherx Biopharma, Inc. – Sarepta Therapeutics, Inc., Gilead Sciences, Inc., Pfizer Inc., Baxter International Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, GlaxoSmithKline plc Sponsored ADR and ... Read more (Read more...)